Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease

Mutagenesis

Volumn 23, Issue 1, 2008, Pages 57-65

  Thomas, Philip ^a,b   Fenech, Michael ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CELL DIVISION; CHEEK; CHROMOSOME 17; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; PRIORITY JOURNAL; TRISOMY;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 21; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA;

EID: 38549181768     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gem044     Document Type: Article

References (63)

1. Burns, A., Byrne, E. J. and Maurer, K. (2002) Alzheimer's disease. Lancet, 360, 163-165.
2. Du, A. T., Schuff, N., Amend, D. et al. (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr., 71, 441-447.
3. Haroutunian, V., Perl, D. P., Purohit, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L. and Mohs, R. C. (1998) Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol., 55, 1185-1191.
4. Kawas, C. H. (2003) Clinical practice. Early Alzheimer's disease. N. Engl. J. Med., 349, 1056-1063.
5. Mattson, M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature, 430, 631-639.
6. St George-Hyslop, P. H. (2000) Piecing together Alzheimer's. Sci. Am., 283, 76-83.
7. Iqbal, K., Grundke-Iqbal, I., Smith, A. J., George, L., Tung, Y. C. and Zaidi, T. (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc. Natl Acad. Sci. USA, 86, 5646-5650.
8. Iqbal, K., Alonso, A. C., Gong, C. X., Khatoon, S., Pei, J. J., Wang, J. Z. and Grundke-Iqbal, I. (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J. Neural Transm. Suppl., 53, 169-180.
9. Hunt, A. J. and McIntosh, J. R. (1998) The dynamic behavior of individual microtubules associated with chromosomes in vitro. Mol. Biol. Cell, 9, 2857-2871.
10. Koo, E. H. (2002) The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic, 3, 763-770.
11. Devenny, D. A., Wegiel, J., Schupf, N., Jenkins, E., Zigman, W., Krinsky-McHale, S. J. and Silverman, W. P. (2005) Dementia of the Alzheimer's type and accelerated aging in Down Syndrome. Sci. Aging Knowledge Environ., 2005, dn1.
12. Maluf, S. W. and Erdtmann, B. (2001) Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet. Cytogenet., 124, 71-75.
13. Wisniewski, H. M., Rabe, A. and Wisniewski, K. E. (1988) Neuropathology and Dementia in People with Down's Syndrome. Cold Spring Harbour Laboratory Press, New York.
14. Franceschi, M., Comola, M., Piattoni, F., Gualandri, W. and Canal, N. (1990) Prevalence of dementia in adult patients with trisomy 21. Am. J. Med. Genet. Suppl., 7, 306-308.
15. Petrozzi, L., Lucetti, C., Scarpato, R., Gambaccini, G., Trippi, F., Bernardini, S., Del Dotto, P., Migliore, L. and Bonuccelli, U. (2002) Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol. Sci., 23 (Suppl. 2), S97-S98.
16. Migliore, L., Boni, G., Bernardini, R., Trippi, F., Colognato, R., Fontana, I., Coppede, F. and Sbrana, I. (2006) Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol. Aging, 27, 710-716.
17. Migliore, L., Testa,A., Scarpato, R., Pavese,N., Petrozzi, L. andBonuccelli,U. (1997) Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum. Genet., 101, 299-305.
18. Migliore, L., Botto, N., Scarpato, R., Petrozzi, L., Cipriani, G. and Bonuccelli, U. (1999) Preferencial occurence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet. Cell Genet., 87, 41-46.
19. Geller, L. N. and Potter, H. (1999) Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis., 6, 167-179.
20. Evers, C. A. and Starr, L. (2006) Biology: Concepts and Applications. 6th edn. Thompson Brooks/Cole, Belmont, CA.
21. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939-944.
22. Belien, J. A., Copper, M. P., Braakhuis, B. J., Snow, G. B. and Baak, J. P. (1995) Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis, 16, 2395-2400.
23. Dunham, I., Lengauer, C., Cremer, T. and Featherstone, T. (1992) Rapid generation of chromosome-specific alphoid DNA probes using the polymerase chain reaction. Hum. Genet., 88, 457-462.
24. Waye, J. S. and Willard, H. F. (1986) Structure, organization, and sequence of alpha satellite DNA from human chromosome 17: evidence for evolution by unequal crossing-over and an ancestral pentamer repeat shared with the human X chromosome. Mol. Cell. Biol., 6, 3156-3165.
25. Pinkel, D., Landegent, J., Collins, C., Fuscoe, J., Segraves, R., Lucas, J. and Gray, J. (1988) Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc. Natl Acad. Sci. USA, 85, 9138-9142.
26. Eastmond, D. A. and Pinkel, D. (1990) Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat. Res., 234, 303-318.
27. Shi, Q., Adler, I. D., Zhang, J., Zhang, X., Shan, X. and Martin, R. (2000) Incidence of mosaic cell lines in vivo and malsegregation of chromosome 21 in lymphocytes in vitro of trisomy 21 patients: detection by fluorescence in situ hybridization on binucleated lymphocytes. Hum. Genet., 106, 29-35.
28. Zivkovic, L., Spremo-Potparevic, B., Djelic, N. and Bajic, V. (2006) Analysis of premature centromere division (PCD) of the chromosome 18 in peripheral blood lymphocytes in Alzheimer disease patients. Mech. Ageing Dev., 127, 892-896.
29. Jenkins, E. C., Schupf, N., Genovese, M. et al. (1997) Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome. Am. J. Med. Genet., 68, 147-151.
30. de Arruda Cardoso Smith, M., Borsatto-Galera, B., Feller, R. I. et al. (2004) Telomeres on chromosome 21 and aging in lymphocytes and gingival fibroblasts from individuals with Down syndrome. J. Oral Sci., 46, 171-177.
31. Teller, J. K., Russo, C., DeBusk, L. M. et al. (1996) Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med., 2, 93-95.
32. Thomas, P. and Fenech, M. (2007) A review of genome mutation and Alzheimer's disease. Mutagenesis, 22, 15-33.
33. Hardy, J. and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci., 12, 383-388.
34. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
35. Neve, R. L., McPhie, D. L. and Chen, Y. (2000) Alzheimer's disease: a dysfunction of the amyloid precursor protein(1). Brain Res., 886, 54-66.
36. Nishimoto, I. (1998) A new paradigm for neurotoxicity by FAD mutants of betaAPP: a signaling abnormality. Neurobiol. Aging, 19, S33-S38.
37. Senechal, Y., Larmet, Y. and Dev, K. K. (2006) Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies. Neurodegener. Dis., 3, 134-147.
38. Iannello, R. C., Crack, P. J., de Haan, J. B. and Kola, I. (1999) Oxidative stress and neural dysfunction in Down syndrome. J. Neural. Transm. Suppl., 57, 257-267.
39. Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H. and Yankner, B. A. (2002) Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron, 33, 677-688.
40. Busciglio, J. and Yankner, B. A. (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature, 378, 776-779.
41. Shukkur, E. A., Shimohata, A., Akagi, T. et al. (2006) Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum. Mol. Genet., 15, 2752-2762.
42. Rozovski, U., Jonish-Grossman, A., Bar-Shira, A., Ochshorn, Y., Goldstein, M. and Yaron, Y. (2007) Genome-wide expression analysis of cultured trophoblastwith trisomy 21 karyotype.Hum. Reprod., 22, 2538-2545.
43. Kimura, R., Kamino, K., Yamamoto, M. et al. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between {beta}-amyloid production and tau phosphorylation in Alzheimer disease. Hum. Mol. Genet., 16, 15-23.
44. Lazarov, O., Morfini, G. A., Pigino, G., Gadadhar, A., Chen, X., Robinson, J., Ho, H., Brady, S. T. and Sisodia, S. S. (2007) Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1. J. Neurosci., 27, 7011-7020.
45. Potter, H. (1991) Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet., 48, 1192-1200.
46. Wang, X., Thomas, P., Xue, J. and Fenech, M. (2004) Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat. Res., 551, 167-180.
47. Schupf, N., Kapell, D., Lee, J. H., Ottman, R. and Mayeux, R. (1994) Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet, 344, 353-356.
48. Rakic, P. (1985) Limits of neurogenesis in primates. Science, 227, 1054-1056.
49. Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A. and Gage, F. H. (1998) Neurogenesis in the adult human hippocampus. Nat. Med., 4, 1313-1317.
50. Li, J., Xu, M., Zhou, H., Ma, J. and Potter, H. (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell, 90, 917-927.
51. Petersen, M. B., Karadima, G., Samaritaki, M., Avramopoulos, D., Vassilopoulos, D. and Mikkelsen, M. (2000) Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome. Am. J. Med. Genet., 93, 366-372.
52. Wragg, M., Hutton, M. and Talbot, C. (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's disease Collaborative Group. Lancet, 347, 509-512.
53. Yamada, M., Sodeyama, N., Itoh, Y., Suematsu, N., Otomo, E., Matsushita, M. and Mizusawa, H. (1997) Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke, 28, 2219-2221.
54. Tyrrel, J., Cosgrave, M., Hawi, Z., Mcpherson, J., Lawlor, B. and Gill, M. (1998) A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Biol. Psychiatr., 43, 397-400.
55. Holtzman, D. M. (1997) Alzheimer disease and Down syndrome. Cytogenet. Cell Genet., 77 (Suppl 1), 17.
56. Avramopoulos, D., Mikkelsen, M., Vassilopoulos, D., Grigoriadou, M. and Petersen, M. B. (1996) Apolipoprotein E allele distribution in parents of Down's syndrome children. Lancet, 347, 862-865.
57. Aisen, P. S., Egelko, S., Andrews, H. et al. (2003) A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am. J. Geriatr. Psychiatry, 11, 246-249.
58. Shea, T. B., Lyons-Weiler, J. and Rogers, E. (2002) Homocysteine, folate deprivation and Alzheimer neuropathology. J. Alzheimers Dis., 4, 261-267.
59. Scarpa, S., Fuso, A., D'Anselmi, F. and Cavallaro, R. A. (2003) Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett., 541, 145-148.
60. Suzuki, T., Fujii, M. and Ayusawa, D. (2002) Demethylation of classical satellite 2 and 3 DNA with chromosomal instability in senescent human fibroblasts. Exp. Gerontol., 37, 1005-1014.
61. Hobbs, C. A., Sherman, S. L., Yi, P., Hopkins, S. E., Torfs, C. P., Hine, R. J., Pogribna, M., Rozen, R. and James, S. J. (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet., 67, 623-630.
62. James, S. J., Pogribna, M., Pogribny, I. P. et al. (1999) Abnormal folate metabolismandmutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am. J. Clin. Nutr., 70, 495-501.
63. O'Leary,V. B., Parle-McDermott,A.,Molloy,A.M., Kirke, P.N., Johnson,Z., Conley, M., Scott, J. M. and Mills, J. L. (2002) MTRR and MTHFR polymorphism: link to Down syndrome? Am. J. Med. Genet., 107, 151-155.